As enterprises modernize, the question is no longer whether to use SAP or non-SAP tools, but how to make them work together ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

Researchers at Rutgers and Stockton universities are deploying a new research buoy they hope will unlock new economic and ...

Monthly trading volume in prediction markets surged from under $100 million in early 2024 to over $13 billion by the end of ...

Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

How Can Kenya’s AI Future Be Built on Trust, Data and Practical Automation - IT News Africa | Business Technology, Telecoms and Startup News ...

REDMOND, Wash. - Data I/O Corporation (NASDAQ:DAIO) announced Thursday changes to its Board of Directors with Edward Smith appointed as Chair of the Board and Steven Waszak joining as a new ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Operationalising green credits for air pollution reduction can mobilise private capital, complement regulatory enforcement, ...

Accessing untrusted digital sources may lead to data compromise, privacy violations, as well as device infection with ...